| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Net income | 65,548 | 64,196 | 226,068 |
| Depreciation, amortization, accretion and other, net | 8,583 | -1,561 | 9,718 |
| Stock-based compensation expense | 3,442 | 2,045 | 8,519 |
| Provision (release) for credit losses | 4,000 | 3,500 | 7,750 |
| Loss (gain) on sale of investment securities | 0 | 0 | 20 |
| Gain on settlements of bank owned life insurance | NaN | NaN | 0 |
| Net realized (gain) loss on sales of premises, equipment, and real estate owned | 40 | 3,825 | 419 |
| Impairment loss on premises and equipment | 0 | 0 | 992 |
| Decrease (increase) in accrued interest receivable | 1,206 | -939 | -4,238 |
| Decrease (increase) in federal and state income tax receivable | 1,580 | -8,877 | -6,124 |
| Decrease (increase) in cash surrender value of bank owned life insurance | 1,976 | 1,962 | 7,526 |
| Decrease (increase) in other assets | -36,743 | -8,127 | 27,885 |
| Increase (decrease) in federal and state income tax liabilities | -4,654 | 5,124 | 0 |
| Increase (decrease) in accrued expenses and other liabilities | -29,482 | -24,980 | 9,393 |
| Net cash provided by (used in) operating activities | 79,378 | 60,480 | 236,952 |
| Origination of loans and principal repayments, net | -148,160 | 253,315 | 973,280 |
| Loans purchased | 0 | 10,198 | 143,605 |
| Fhlb & frb stock purchase | NaN | NaN | 496,542 |
| Fhlb stock purchased | 185,665 | 177,116 | NaN |
| Fhlb & frb stock redeemed | NaN | NaN | 504,092 |
| Fhlb stock redeemed | 157,532 | 146,966 | NaN |
| Available-for-sale securities purchased | 342,975 | 724,749 | 1,482,058 |
| Principal payments and maturities of available-for-sale securities | 119,094 | 128,421 | 561,808 |
| Proceeds from sales of available-for-sale securities | 0 | 0 | 797 |
| Held-to-maturity securities purchased | -220 | 141,283 | 261,842 |
| Principal payments and maturities of held-to-maturity securities | 18,981 | 22,428 | 53,030 |
| Proceeds from sales of real estate owned | 982 | 2,963 | 2,865 |
| Proceeds from settlements of bank owned life insurance | NaN | NaN | 0 |
| Equity method investments purchased | 0 | 0 | 2,861 |
| Net cash received (paid) in business combinations | 3,400 | 2,000 | 360 |
| Proceeds from sales of loans | NaN | NaN | 0 |
| Proceeds from sales of premises and equipment | 3,750 | 6 | 1,689 |
| Premises and equipment purchased and reo improvements | 11,410 | 10,441 | 28,707 |
| Net cash provided by (used in) investing activities | -391,051 | -511,688 | -318,414 |
| Net increase (decrease) in customer accounts | -292,819 | -20,666 | 63,666 |
| Proceeds from borrowings | 4,125,000 | 3,875,750 | 11,019,793 |
| Repayments of borrowings | 3,499,999 | 3,205,751 | 12,527,894 |
| Principal payments and maturities of senior debt | NaN | NaN | 0 |
| Proceeds from stock-based awards | 475 | 488 | 3,943 |
| Dividends paid on common stock | 20,157 | 20,362 | 84,639 |
| Dividends paid on preferred stock | 3,657 | 3,656 | 14,625 |
| Proceeds from employee stock purchases | 253 | 184 | 842 |
| Treasury stock purchased | 87,207 | 58,017 | 101,931 |
| Increase (decrease) in advances payments by borrowers for taxes and insurance | 24,668 | -39,157 | -1,485 |
| Net cash provided by (used in) financing activities | 246,557 | 528,813 | -1,642,330 |
| Increase (decrease) in cash and cash equivalents | -65,116 | 77,605 | -1,723,792 |
| Cash, cash equivalents and restricted cash at beginning of period | 734,915 | 657,310 | 2,381,102 |
| Cash, cash equivalents and restricted cash at end of period | 669,799 | 734,915 | 657,310 |
WAFD INC (WAFDP)
WAFD INC (WAFDP)